Determination of the Efficacy of Slendertone® Face to Tone the Muscles of the Face and Reduce the Signs of Facial Aging

Inclusion Criteria:

• Healthy (by their own report) female participants aged between 35 and 55

• Visual signs of aging of the face

• Able and willing to complete all study assessments and to be followed for the fullcourse of the study.

• Able to read, write and follow instructions in English.

• Able and willing to provide informed consent.

Exclusion Criteria:

• Pregnant women (or pregnancy within last 3 months).

• Inadequate precaution or procedure to prevent pregnancy (women of child- bearingpotential only).

• Individuals who have any implanted medical devices (pacemaker, pump, catheter, etc.)

• Current or history of a medical condition that would contraindicate treatment with theproduct, such as epilepsy, hernia, abdominal ulcer, diabetes, or other conditionswhich, in the opinion of the Investigator, would place the participant at risk.

• A current skin disease of any type at the test site (e.g. acne, eczema, psoriasis,burns, abrasions, etc.)

• Heavy alcohol consumption in the opinion of the investigator.

• A fever in the last 12 hours prior to the first application of the test device.

• History of heart disease.

• History of stroke.

• History of malignant disease.

• Insulin dependent diabetes.

• Concurrent medication likely to affect the response to the test article or confuse theresults of the study (e.g. routine high dose use of any drugs that may artificiallyaffect skin tone).

• Individuals who are currently participating in any other clinical. investigation, orwho have participated in a study with the same indication within 1 year.

• Principal investigator for this study, or member of study staff.

• Individuals who have had facial surgery.

• Individuals who use BOTOX. (The latter two exclusions were applied because of thepossibility of an altered anatomical or physiological background which may haveinterfered with the effectiveness of the treatment).